S

Simply Better Brands Corp
XTSX:SBBC

Watchlist Manager
Simply Better Brands Corp
XTSX:SBBC
Watchlist
Price: 0.85 CAD -2.3% Market Closed
Market Cap: 90.6m CAD

Relative Value

SBBC doesn't have a meaningful market cap.

The Relative Value of one SBBC stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.85 CAD, Simply Better Brands Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBBC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
34
vs Industry
56
Median 3Y
0.5
Median 5Y
0.7
Industry
2.4
Forward
1.3
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.9
Industry
20.6
Forward
-20.1
vs History
vs Industry
19
Median 3Y
-9.6
Median 5Y
-14.1
Industry
15.5
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-5.3
Industry
23
vs History
21
vs Industry
5
Median 3Y
1.9
Median 5Y
1.8
Industry
1.9
vs History
34
vs Industry
56
Median 3Y
0.6
Median 5Y
0.7
Industry
2.5
Forward
1.3
vs History
34
vs Industry
50
Median 3Y
1
Median 5Y
1.1
Industry
4.9
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-11.6
Industry
12.6
Forward
25.5
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-8.3
Industry
15.7
vs History
vs Industry
16
Median 3Y
-12.4
Median 5Y
-21.2
Industry
14
vs History
vs Industry
16
Median 3Y
-12.4
Median 5Y
-17.7
Industry
17.7
vs History
43
vs Industry
11
Median 3Y
3
Median 5Y
5
Industry
1.8

Multiples Across Competitors

SBBC Competitors Multiples
Simply Better Brands Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Simply Better Brands Corp
XTSX:SBBC
90.6m CAD 1.4 -7.5 -41.9 -18.3
US
Eli Lilly and Co
NYSE:LLY
838.1B USD 18.6 79.1 45.9 50.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
372.1B USD 4.2 17.1 12.4 16.3
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK 6.2 17.7 11.7 13.4
CH
Roche Holding AG
SIX:ROG
208.3B CHF 3.4 25.2 9.5 11.1
CH
Novartis AG
SIX:NOVN
187.4B CHF 4.4 19 11.5 14.7
UK
AstraZeneca PLC
LSE:AZN
161.3B GBP 4 30.5 126.2 192.7
US
Merck & Co Inc
NYSE:MRK
209.1B USD 3.3 12 8.6 10.3
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
FR
Sanofi SA
PAR:SAN
115.8B EUR 1.3 9.1 5 5.9
P/E Multiple
Earnings Growth PEG
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average P/E: 26.2
Negative Multiple: -7.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
79.1
49%
1.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.1
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
17.7
18%
1
CH
Roche Holding AG
SIX:ROG
25.2
32%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
30.5
36%
0.8
US
Merck & Co Inc
NYSE:MRK
12
18%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
FR
Sanofi SA
PAR:SAN
9.1
28%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average EV/EBITDA: 433.8
Negative Multiple: -41.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
45.9
31%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.4
8%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
14%
0.8
CH
Roche Holding AG
SIX:ROG
9.5
6%
1.6
CH
Novartis AG
SIX:NOVN
11.5
5%
2.3
UK
AstraZeneca PLC
LSE:AZN
126.2
9%
14
US
Merck & Co Inc
NYSE:MRK
8.6
9%
1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
FR
Sanofi SA
PAR:SAN
5
8%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average EV/EBIT: 1 867.3
Negative Multiple: -18.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
50.7
33%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.3
12%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
16%
0.8
CH
Roche Holding AG
SIX:ROG
11.1
8%
1.4
CH
Novartis AG
SIX:NOVN
14.7
8%
1.8
UK
AstraZeneca PLC
LSE:AZN
192.7
21%
9.2
US
Merck & Co Inc
NYSE:MRK
10.3
12%
0.9
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
FR
Sanofi SA
PAR:SAN
5.9
14%
0.4